2Seifer M,Hamatake RK,Colonno RJ,et al.In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.Antimicrob Agents Chemother,1998,42:3200-3208.
3Lurie Y,Manns MP,Gish RG,et al.The Efficacy of entecavir is similar regardless of disease-related baseline subgroups in treatment of nucleoside-naive,HBeAg(+) and HBeAg(-) patients with chronic hepatitis B.Presented at 40th EASL 2005.
4Lai CL,Chang TT,Chao YC,et al.Entecavir demonstrates superior histologic and virologic efficacy over lamivudine in nucleoside-naive HBeAg(-) chronic hepatitis B:results of phase Ⅲ trial ETV-027.The 14th Biennial Conference of APASL 2004.
5Chao YC,Chang TT,Lai CL,et al.Decline in serum HBV DNA and ALT normalisation is associated with histological improvement among nucleoside-naive patients in entecavir phase Ⅲ trials.The 15th Biennial Conference of APASL 2005.
6Bonino F,Brunetto MR.Chronic hepatitis B e antigen (HBeAg) negative,anti-HBe positive hepatitis B:an overview.J Hepatol,2003,39 Suppl 1:S160-S163.
7de Franchis R,Hadengue A,Lau G,et al.EASL International Consensus Conference on Hepatitis B.13-14 September,2002 Geneva,Switzerland.Consensus statement (long version).J Hepatol,2003,39Suppl 1:S3-S25.
8Gish RG,Chang T,Man D,et al,Entecavir results in substantial virologic and biochemical improvement and HBeAg seroconversion through 96 weeks of treatment in HBeAg(+) chronic hepatitis B patients (Study ETV-022).AASLD 56th Annual Meeting.
4Hsu HM, Lu CF, Lee SC, et al. Seroepidemiology surey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immuination. J Infect Dis, 1999,179:367-370.
5WHO.Hepatitis B surface antigen assay: operational characteristics.2000.1-15.
6Norihiro F,Jun H,Yasunori S.The elimination Of hepatitis B virus infection:changing seroepidemiology of hepatitis A and B virus infection in Okinawa Japan over a 26-year period Am J Med Hyp,1998.59:693—698.
10Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
